current research
|
|
PUBLICATIONS
Tanner MR, O’Shea JG, Byrd KM, et al. Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025. MMWR Recomm Rep 2025;74(No. RR-1):1–56.
Guidelines for HIV post-exposure prophylaxis. Geneva: World Health Organization; 2024. Licence: CC BY-NCSA 3.0 IGOWorld Health Organization.
Li J, Liu Y, Nehl E, Tucker JD. A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation. Curr Opin HIV AIDS. 2024.
Billick MJ, Sheps J, Bogoch II. HIV prevention with postexposure prophylaxis-in-pocket (PIP). BMJ. 2023 Aug 2;382:e076016.
Billick MJ, Fisher KN, Myers S, Tan DHS, Bogoch II. Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, Canada. J Acquir Immune Defic Syndr. 2023 Nov 1;94(3):211-213.
Clifford Rashotte M, Yoong D, Naccarato M, et al. Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures. International Journal of STD & AIDS. 2023;0(0).
Wood BR. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket). AIDS. 2020 Mar 1;34(3):481-482.
Alghamdi A, Hempel A, Heendeniya A, Clifford-Rashotte M, Tan DHS, Bogoch II. HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures. AIDS. 2020 Mar 1;34(3):433-437.
Tumarkin E, Heendeniya A, Murphy P, Placido T, Tan DHS, Bogoch II. Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures. J Acquir Immune Defic Syndr. 2018 May 1;78(1):20-22.
Guidelines for HIV post-exposure prophylaxis. Geneva: World Health Organization; 2024. Licence: CC BY-NCSA 3.0 IGOWorld Health Organization.
Li J, Liu Y, Nehl E, Tucker JD. A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation. Curr Opin HIV AIDS. 2024.
Billick MJ, Sheps J, Bogoch II. HIV prevention with postexposure prophylaxis-in-pocket (PIP). BMJ. 2023 Aug 2;382:e076016.
Billick MJ, Fisher KN, Myers S, Tan DHS, Bogoch II. Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, Canada. J Acquir Immune Defic Syndr. 2023 Nov 1;94(3):211-213.
Clifford Rashotte M, Yoong D, Naccarato M, et al. Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures. International Journal of STD & AIDS. 2023;0(0).
Wood BR. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket). AIDS. 2020 Mar 1;34(3):481-482.
Alghamdi A, Hempel A, Heendeniya A, Clifford-Rashotte M, Tan DHS, Bogoch II. HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures. AIDS. 2020 Mar 1;34(3):433-437.
Tumarkin E, Heendeniya A, Murphy P, Placido T, Tan DHS, Bogoch II. Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures. J Acquir Immune Defic Syndr. 2018 May 1;78(1):20-22.
For more information, please contact our research manager:
Karla Fisher | [email protected]
Karla Fisher | [email protected]